Connect with us
The Association of Biotechnological Companies shows its interest in concentrating biotechnological companies in the city and promoting public-private collaboration. The Councilor for Employment and Local Development...
Celyad Oncology—a biotech startup creating a highly specialized treatment for relapsing multiple myeloma patients—has just had its clinical trial validated by the FDA. A major milestone...
In 2015, Nostoc closed the first round of investment worth $296,000 (€250,000) through the Social Exchange's participatory investment platform. Since then, the company has been growing...
Nantes-based biotech company Xenothera is developing Xav-19, a promising antibody for the treatment of COVID-19. Initially announced for the end of June, the start of the...
In March, BioNTech's share price, after rallying to $105, plummeted in two stages to initially $43.66 and then, after an interim recovery to $64.45, to $37....
Almirall cuts its profits as a result of the coronavirus crisis. The Spanish pharmaceutical company justifies this result by the negative impact on the area of...
Celyad Oncology has just had a clinical trial validated by the FDA, a major milestone in the development of Nasdaq-listed biotech company. On Tuesday, July 14th,...
The company Varmx is developing an innovative drug for the treatment and prevention of severe bleeding in patients treated with oral anticoagulants. VarmX's most advanced product,...
Alta Life Sciences leads a $3.94 million (€3.5 million) round at DeepUII. With this capital injection, the Spanish company covers the financial needs to validate the...
The Gosselies Biopark company has filed an IPO application with the SEC, the U.S. regulator, has announced the Wall Street Stock Exchange with a strong technology...